Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02748148 · ClinicalTrials.gov registry record · NA
Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice
A NA study of Medication Therapy Management and Pharmacogenomics, sponsored by Tabula Rasa HealthCare.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT02748148 is a NA study of Medication Therapy Management and Pharmacogenomics that has completed, run by Tabula Rasa HealthCare. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02748148, a NA study of Medication Therapy Management and Pharmacogenomics, has completed, sponsored by Tabula Rasa HealthCare.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify challenges and successes associated with implementing an enhanced medication therapy management service in primary care practice.
Conditions Studied
Interventions
- OTHER Medication therapy management
Study Locations (1)
New Jersey
- Elmwood Family Physicians - Marlton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02748148
The ClinicalTrials.gov registry entry for NCT02748148 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tabula Rasa HealthCare, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Medication Therapy Management appearing as the primary indexed condition, and to 1 intervention - of which Medication therapy management is the first listed.
NCT02748148 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT02748148 about?
NCT02748148 is a clinical study titled "Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice". The purpose of this study is to identify challenges and successes associated with implementing an enhanced medication therapy management service in primary care practice.
What is the current status of trial NCT02748148?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-04. Estimated completion is 2016-09.
What conditions does trial NCT02748148 study?
This clinical trial studies the following conditions: Medication Therapy Management, Pharmacogenomics.
What interventions are being tested in trial NCT02748148?
The interventions under investigation include: Medication therapy management (OTHER).
Who is sponsoring clinical trial NCT02748148?
This trial is sponsored by Tabula Rasa HealthCare, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02748148 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Medication Therapy Management
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.